|
Beijing Genomics Institute Signs Global Site License with CLC bio for Sequencing Software Platform
04 July 2008
The global site license agreement, for CLC Genomics Workbench, covers all researchers at all BGI sites, both inside and outside of China.
|
|
|
|
ClinPhone and Cytel - A New Partnership Delivering Complete Solutions for Adaptive Clinical Trials
03 July 2008
Partnership combines Cytel's validated adaptive trial statistical and computational expertise with ClinPhone's suite of clinical technologies and operational know-how.
|
|
|
|
Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration
02 July 2008
AstraZeneca and Palatin amend their collaboration agreement to discover, develop and commercialize compounds that target melanocortin receptors.
|
|
|
|
Ipsogen Accelerates Its Development in Europe with the CE marking of its JAK2 Diagnostic Kits
01 July 2008
Ipsogen’s JAK2 V617F diagnostic kits are now available to all European diagnostic laboratories.
|
|
|
|
Millipore Unveils Expanded Drug Discovery Development Facility
30 June 2008
The $3.4 million expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business.
|
|
|
|
Lab21 Expands Cancer Gene Testing Service
27 June 2008
Lab21 has now added an epidermal growth factor receptor mutation test to its existing range.
|
|
|
|
Eden Biodesign Confirms Research Triangle Park Facility
26 June 2008
The Company expands US operation to offer a range of cell line/strain development and early process development services.
|
|
|
|
Pluristem Certified as a Good Manufacturing Practices Site for the Manufacture of PLX cells for its Clinical Trials
26 June 2008
The GMP certification has been approved for the purpose of manufacturing PLX cells which will be shipped to the EU for use in the Company’s upcoming clinical trials.
|
|
|
|
ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North America
25 June 2008
IonGate will leverage ARTEL’s expertise to increase the exposure and use of its discovery systems and assay development services in North America.
|
|
|
|
The NITD and the TB Alliance Announce Five-Year Collaboration Targeted to Accelerate TB treatment R&D
25 June 2008
The collaboration aims to move projects from the research phase through the translational stage and into development.
|
|
|
|
Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
24 June 2008
The contract manufacturing company has started operation of a 2,500 L multi-process production suite.
|
|
|
|
OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Obesity Candidate, PSN602
24 June 2008
PSN602 is an oral dual serotonin and norepinephrine reuptake inhibitor and 5-HT1A agonist, being developed for the treatment of obesity.
|
|
|
|
GE Healthcare Launches Customized Training Courses for Improving Customers’ Biopharmaceutical Processes
24 June 2008
The new courses are an extension of GE Healthcare’s Fast Trak™ Training and Education programme offering.
|
|
|
|
Boehringer Ingelheim and GENEART Collaborate to Provide DNA Therapeutics and Vaccines
24 June 2008
The collaboration offers customers an integrated system solution from the design to the production of DNA-based pharmaceutical agents.
|
|
|
|
iCeutica Completes GMP Scale-Up for its Nano-Sized Products
24 June 2008
iCeutica has used its nano-sizing technology to manufacture the first GMP clinical supplies for its partner, Iroko Pharmaceuticals.
|
|
|
|
Idealp-Pharma Launches ‘Hit-To-Candidate’ Services
20 June 2008
Idealp-Pharma is launching fully integrated drug discovery and preclinical development services to speed up partner’s and client’s small molecules programs.
|
|
|
|
Celleron Therapeutics Establishes in Oxford, UK
20 June 2008
The Company has two oncology programmes in clinical development, a strong pre-clinical pipeline and a targeting biomarker capability, CancerNav™.
|
|
|
|
SMI Launches Patient Recruitment Arm to Increase Enrollment in Clinical Trials
19 June 2008
Point-of-Care marketing company leveraging out-of-home media tactics to inform physicians, increase volunteers for clinical trials.
|
|
|
|
ThromboGenics and BioInvent Announce a Strategic Alliance with Roche for an Anti-Cancer Antibody
18 June 2008
Under the terms of the agreement, Roche will pay ThromboGenics and BioInvent an upfront payment of EUR50 million.
|
|
|
|
Corning Announces Significant Milestone in High-Throughput Label-Free Screening for Drug Development
13 June 2008
Scientists performed two 100,000-compound screens in high throughput using Corning® Epic® System.
|
|
|
|
Pfizer and UCSF Form Alliance to Advance a Broad Range of Research
12 June 2008
Pfizer, Inc. and UCSF have launched a collaboration to span many disciplines, several UC campuses and multiple Pfizer research units.
|
|
|